http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-H0892089-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_fc3e5cb7a2da33ea01dae32f31bef542 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P13-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D497-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P15-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-435 |
| filingDate | 1994-09-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f62a9d77ef0ed4784f9ddd2a6c7957fd http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7b38d5c67a81e2a3ddf82e0dbf0565bb |
| publicationDate | 1996-04-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-H0892089-A |
| titleOfInvention | Driver Jain remedy |
| abstract | (57) [Summary] (Modified) [Structure] A therapeutic agent for driver jain which comprises a spirooxathiolane quinuclidine derivative represented by the following formula (I) or an acid addition salt thereof as an active ingredient. (In the formula, R 1 and R 2 may be the same or different and each is hydrogen, alkyl, cyclopentyl, Cyclohexyl, aryl or diaryl methylol, Or, is an alkyl substituted with one or more aryl groups. ) Particularly, cis-2-methylspiro (1,3-oxathiolane-5,3 ') quinuclidine hydrochloride addition salt is preferable. [Effect] By treating the above therapeutic agent orally or parenterally, driver gyna disease (symptom of abnormal dryness of vagina, vulva, etc.) is treated. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AU-760180-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6410557-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0041691-A1 |
| priorityDate | 1994-09-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 34.